$24.750
+0.020 (+0.08%)At close
- High
- 24.800
- Open
- 24.800
- VWAP
- 24.75
- Volume
- 1.58K
- Mkt Cap
- —
- Low
- 24.688
- Amount
- 39.17K
- EV/EBITDA, TTM
- —
AI analysis of SAV (SAV)
BuyCassava Sciences Inc (SAVA) appears to be a good buy right now, especially considering its current price of 2.38, which is well below its 52-week high of 3.45. The recent closure of the DOJ investigation and the company's strategic rebranding to Filana Therapeutics are positive catalysts that could enhance investor confidence. Additionally, the RSI is at 66.474, indicating strong momentum, while the stock has seen a 16.10% increase over the last 20 days, suggesting a bullish trend. However, the main risk is the company's negative net income, which was -44224000 in Q2 2025, highlighting ongoing financial challenges that investors should monitor closely.
SAV FAQ — answered by Alphio AI
Cassava Sciences Inc (SAVA) appears to be a good buy right now, especially considering its current price of 2.38, which is well below its 52-week high of 3.45. The recent closure of the DOJ investigation and the company's strategic rebranding to Filana Therapeutics are positive catalysts that could enhance investor confidence. Additionally, the RSI is at 66.474, indicating strong momentum, while the stock has seen a 16.10% increase over the last 20 days, suggesting a bullish trend. However, the main risk is the company's negative net income, which was -44224000 in Q2 2025, highlighting ongoing financial challenges that investors should monitor closely.
Community
More ↗No posts yet
Sign up or log in to join the discussionRelated articles
- Treasury Yields and the Stock Market: What a Near-5% 10-Year Yield Means for Investors in 2026The 10-year Treasury yield hit 5.31% in October 2026 before easing to 4.88%. Learn how Treasury yields affect stocks, which sectors react and how to plan.
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.